Your search returned 7142 results.

Results
	7001.	MET increases the sensitivity of gefitinib-resistant cells to SN-38, an active metabolite of irinotecan, by up-regulating the topoisomerase I activity. [electronic resource] by Sakai, Asao Kasahara, Kazuo Ohmori, Tohru Kimura, Hideharu Sone, Takashi Fujimura, Masaki Nakao, Shinji Producer: 20130117 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7002.	Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibition. [electronic resource] by Mayes, Patrick A Degenhardt, Yan Y Wood, Andrew Toporovskya, Yana Diskin, Sharon J Haglund, Elizabeth Moy, Christopher Wooster, Richard Maris, John M Producer: 20130129 In: International journal of cancer vol. 132 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7003.	Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens. [electronic resource] by Ng, Kimmie Tabernero, Josep Hwang, Jimmy Bajetta, Emilio Sharma, Sunil Del Prete, Salvatore A Arrowsmith, Edward R Ryan, David P Sedova, Michaela Jin, Jin Malek, Kamel Fuchs, Charles S Producer: 20140205 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7004.	Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53. [electronic resource] by Zhang, Shengliang Zhou, Lanlan Hong, Bo van den Heuvel, A Pieter J Prabhu, Varun V Warfel, Noel A Kline, Christina Leah B Dicker, David T Kopelovich, Levy El-Deiry, Wafik S Producer: 20160104 In: Cancer research vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7005.	EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer. [electronic resource] by Ålgars, Annika Sundström, Jari Lintunen, Minnamaija Jokilehto, Terhi Kytölä, Soili Kaare, Milja Vainionpää, Reetta Orpana, Arto Österlund, Pia Ristimäki, Ari Carpen, Olli Ristamäki, Raija Producer: 20170623 In: International journal of cancer vol. 140 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7006.	Late-stage inhibition of autophagy enhances calreticulin surface exposure. [electronic resource] by Li, Dan-Dan Xie, Bo Wu, Xiao-Jun Li, Jing-Jing Ding, Ya Wen, Xi-Zhi Zhang, Xing Zhu, Shu-Guang Liu, Wei Zhang, Xiao-Shi Peng, Rui-Qing Producer: 20180222 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7007.	Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial. [electronic resource] by DuBois, Steven G Marachelian, Araz Fox, Elizabeth Kudgus, Rachel A Reid, Joel M Groshen, Susan Malvar, Jemily Bagatell, Rochelle Wagner, Lars Maris, John M Hawkins, Randall Courtier, Jesse Lai, Hollie Goodarzian, Fariba Shimada, Hiroyuki Czarnecki, Scarlett Tsao-Wei, Denice Matthay, Katherine K Mosse, Yael P Producer: 20160906 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7008.	The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux. [electronic resource] by Erlichman, C Boerner, S A Hallgren, C G Spieker, R Wang, X Y James, C D Scheffer, G L Maliepaard, M Ross, D D Bible, K C Kaufmann, S H Producer: 20010222 In: Cancer research vol. 61 Availability: No items available. Save to lists Add to cart (remove)
	7009.	Lung cancer: therapeutic options for stage IV and recurrent NSCLC. [electronic resource] by Calvo, A R Belani, C P Producer: 20010517 In: Cancer treatment and research vol. 105 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7010.	Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. [electronic resource] by Swisher, Stephen G Maish, Mary Erasmus, Jeremy J Correa, Arlene M Ajani, Jaffer A Bresalier, Robert Komaki, Ritsuko Macapinlac, Homer Munden, Reginald F Putnam, Joe B Rice, David Smythe, W Roy Vaporciyan, Ara A Walsh, Garrett L Wu, Tsung T Roth, Jack A Producer: 20050630 In: The Annals of thoracic surgery vol. 78 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7011.	Phase I dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignancies. [electronic resource] by Becerra, Carlos R Verma, Udit N Tran, Hia T Tavana, Denise Williams, Noelle S Frenkel, Eugene P Producer: 20080612 In: American journal of clinical oncology vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7012.	Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha. [electronic resource] by Chintala, Sreenivasulu Tóth, Károly Cao, Shousong Durrani, Farukh A Vaughan, Mary M Jensen, Randy L Rustum, Youcef M Producer: 20100908 In: Cancer chemotherapy and pharmacology vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7013.	Pharmacogenetic profiling for cetuximab plus irinotecan therapy in patients with refractory advanced colorectal cancer. [electronic resource] by Graziano, Francesco Ruzzo, Annamaria Loupakis, Fotios Canestrari, Emanuele Santini, Daniele Catalano, Vincenzo Bisonni, Renato Torresi, Umberto Floriani, Irene Schiavon, Gaia Andreoni, Francesca Maltese, Paolo Rulli, Eliana Humar, Bostjan Falcone, Alfredo Giustini, Lucio Tonini, Giuseppe Fontana, Andrea Masi, Gianluca Magnani, Mauro Producer: 20080327 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7014.	HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer. [electronic resource] by Kageyama, Taihei Nagashio, Ryo Ryuge, Shinichiro Matsumoto, Toshihide Iyoda, Akira Satoh, Yukitoshi Masuda, Noriyuki Jiang, Shi-Xu Saegusa, Makoto Sato, Yuichi Producer: 20120801 In: Asian Pacific journal of cancer prevention : APJCP vol. 12 Availability: No items available. Save to lists Add to cart (remove)
	7015.	Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer. [electronic resource] by Soeda, Hiroshi Shimodaira, Hideki Watanabe, Mika Suzuki, Takao Gamoh, Makio Mori, Takahiro Komine, Keigo Iwama, Noriyuki Kato, Shunsuke Ishioka, Chikashi Producer: 20140403 In: International journal of clinical oncology vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7016.	Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy: a pooled analysis of three trials. [electronic resource] by Modest, Dominik P Brodowicz, Thomas Stintzing, Sebastian Jung, Andreas Neumann, Jens Laubender, Ruediger P Ocvirk, Janja Kurteva, Galina Papai, Zsuzsanna Knittelfelder, Regina Kirchner, Thomas Heinemann, Volker Zielinski, Christoph C Producer: 20121210 In: Oncology vol. 83 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7017.	Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas. [electronic resource] by Bautista, Francisco Paci, Angelo Minard-Colin, Veronique Dufour, Christelle Grill, Jacques Lacroix, Ludovic Varlet, Pascale Valteau-Couanet, Dominique Geoerger, Birgit Producer: 20140604 In: Pediatric blood & cancer vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7018.	The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2. [electronic resource] by Skrypek, Nicolas Vasseur, Romain Vincent, Audrey Duchêne, Bélinda Van Seuningen, Isabelle Jonckheere, Nicolas Producer: 20160229 In: Oncotarget vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7019.	Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC). [electronic resource] by Allendorf, Daniel J Bordoni, Rodolfo E Grant, Stefan C Saleh, Mansoor N Reddy, Vishnu B Jerome, Mary L Dixon, Pamela M Miley, Deborah K Singh, Karan P Robert, Francisco Producer: 20160128 In: Cancer chemotherapy and pharmacology vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7020.	The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia. [electronic resource] by Zhang, Jun Zhou, Lanlan Zhao, Shuai Dicker, David T El-Deiry, Wafik S Producer: 20180412 In: Cell cycle (Georgetown, Tex.) vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 7142 results.